Ironwood Pharmaceuticals | IRWD - Debt



Ironwood Pharmaceuticals reported $583.99M in Debt for its fiscal quarter ending in December of 2024.


Debt Change Date
Acadia Pharmaceuticals USD 56.29M 56.29M Jun/2025
Agios Pharmaceuticals USD 48.76M 48.76M Jun/2025
Almirall EUR 341.5M 67.31M Mar/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Amarin USD 0 0 Mar/2025
Ardelyx USD 206.64M 55.79M Jun/2025
Astellas Pharma JPY 831.43B 83.94B Mar/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Charles River Laboratories USD 2.79B 275.28M Jun/2025
Exact Sciences USD 2.32B 16.28M Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Incyte USD 42.41M 5.29M Jun/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
MacroGenics USD 37.25M 37.25M Jun/2025
Moderna USD 741M 4M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacira USD 580.49M 2.88M Jun/2025
PTC Therapeutics USD 286.01M 2.12B Jun/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Takeda JPY 4.51T 9.32B Jun/2025
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025